Barrett Christopher D, Moore Hunter B, Banerjee Anirban, Silliman Christopher C, Moore Ernest E, Yaffe Michael B
From the Koch Institute for Integrative Cancer Research (C.D.B.), Massachusetts Institute of Technology, Cambridge, Massachusetts; Department of Surgery (C.D.B.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Departments of Surgery (H.B.M., A.B., E.E.M.) and Pediatrics (C.C.S.), University of Colorado Denver, Denver, Colorado; Bonfils Blood Center (C.C.S.), Denver, Colorado; Department of Surgery (E.E.M.), Denver Health Medical Center, Denver, Colorado; Koch Institute (M.B.Y.), Massachusetts Institute of Technology, Cambridge, Massachusetts; and Division of Acute Care Surgery and Critical Care, Department of Surgery (M.B.Y.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
J Trauma Acute Care Surg. 2017 Dec;83(6):1053-1061. doi: 10.1097/TA.0000000000001685.
A subset of trauma patients undergo fibrinolysis shutdown rather than pathologic hyperfibrinolysis, contributing to organ failure. The molecular basis for fibrinolysis shutdown in trauma is incompletely understood. Elastase released from primed/activated human neutrophils (HNE) has historically been described as fibrin(ogen)olytic. However, HNE can also degrade plasminogen (PLG) to angiostatin (ANG), retaining the kringle domains but not the proteolytic function, and could thereby compete for generation of active plasmin by tissue plasminogen activator (tPA). We hypothesized that HNE can drive fibrinolysis shutdown rather than fibrinolysis.
Turbidometry was performed using light scatter (λ = 620 nm) in a purified fibrinogen + PLG system and in healthy citrate plasma clotted with Ca/thrombin ± tPA, ±HNE, and ±ANG to evaluate HNE effects on fibrinolysis, quantified by time to transition midpoint (Tm). ΔTm from control is reported as percent of control ±95% CI. Purified HNE coincubated with PLG or tPA was analyzed by western blot to identify cleavage products. Exogenous HNE was mixed ex vivo with healthy volunteer blood (n = 7) and used in TEG ± tPA to evaluate effects on fibrinolysis.
HNE did not cause measurable fibrinolysis on fibrin clots, clotted plasma, or whole blood as assessed by turbidometry or TEG in the absence of tPA. Upon tPA treatment, all three methods of evaluating fibrinolysis showed delays and decreases in fibrinolysis caused by HNE relative to control: fibrin clot turbidometry ΔTm = 110.7% (CI 105.0-116.5%), clotted citrate plasma (n = 6 healthy volunteers) ΔTm = 126.1% (CI 110.4-141.8%), and whole blood native TEG (n = 7 healthy volunteers) with ΔLY30 = 28% (p = 0.043). Western blot analysis of HNE-PLG co-incubation confirmed that HNE generates angiostatin K1-3, and plasma turbidity assays treated with angiostatin K1-3 delayed fibrinolysis.
HNE degrades PLG and generates angiostatin K1-3, which predominates over HNE cleavage of fibrin(ogen). These findings suggest that neutrophil release of elastase may underlie trauma-induced fibrinolytic shutdown.
一部分创伤患者会出现纤维蛋白溶解停止而非病理性纤维蛋白溶解亢进,这会导致器官功能衰竭。创伤中纤维蛋白溶解停止的分子基础尚未完全明确。从致敏/活化的人类中性粒细胞(HNE)释放的弹性蛋白酶历来被描述为具有纤维蛋白(原)溶解作用。然而,HNE也可将纤溶酶原(PLG)降解为血管抑素(ANG),保留kringle结构域但不保留蛋白水解功能,从而可能与组织型纤溶酶原激活剂(tPA)竞争生成活性纤溶酶。我们推测HNE可导致纤维蛋白溶解停止而非促进纤维蛋白溶解。
在纯化的纤维蛋白原+PLG系统以及用钙/凝血酶±tPA、±HNE和±ANG凝结的健康枸橼酸盐血浆中,使用光散射(λ = 620 nm)进行比浊法检测,以评估HNE对纤维蛋白溶解的影响,通过转变中点时间(Tm)进行量化。相对于对照组的ΔTm以对照组的百分比±95%可信区间报告。将纯化的HNE与PLG或tPA共同孵育后进行蛋白质印迹分析,以鉴定裂解产物。将外源性HNE与健康志愿者血液(n = 7)在体外混合,并用于血栓弹力图(TEG)±tPA检测,以评估对纤维蛋白溶解的影响。
在没有tPA的情况下,通过比浊法或TEG评估,HNE对纤维蛋白凝块、凝结血浆或全血均未引起可测量的纤维蛋白溶解。在tPA治疗后,所有三种评估纤维蛋白溶解的方法均显示,相对于对照组,HNE导致纤维蛋白溶解延迟和减少:纤维蛋白凝块比浊法ΔTm = 110.7%(可信区间105.0 - 116.5%),枸橼酸盐凝结血浆(n = 6名健康志愿者)ΔTm = 126.1%(可信区间110.4 - 141.8%),全血天然TEG(n = 7名健康志愿者),ΔLY30 = 28%(p = 0.043)。HNE与PLG共同孵育的蛋白质印迹分析证实,HNE生成血管抑素K1 - 3,用血管抑素K1 - 3处理的血浆比浊法检测显示纤维蛋白溶解延迟。
HNE降解PLG并生成血管抑素K1 - 3,这在HNE对纤维蛋白(原)的裂解作用中占主导地位。这些发现表明,中性粒细胞释放弹性蛋白酶可能是创伤诱导的纤维蛋白溶解停止的基础。